title: Leflunomide-associated progressive multifocal leukoencephalopathy.
authors.affiliation: Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.
authors.forename: Megan
authors.initials: M
authors.lastname: Rahmlow
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Shuster
authors.forename: Jacob
authors.initials: J
authors.lastname: Dominik
authors.forename: H Gordon
authors.initials: HG
authors.lastname: Deen
authors.forename: Dennis W
authors.initials: DW
authors.lastname: Dickson
authors.forename: Allen J
authors.initials: AJ
authors.lastname: Aksamit
authors.forename: Hector A
authors.initials: HA
authors.lastname: Robles
authors.forename: William D
authors.initials: WD
authors.lastname: Freeman
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001706:Biopsy; D001921:Brain / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007275:Injections, Intravenous; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077339:Leflunomide; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012640:Seizures / Q000209:etiology; D013194:Staining and Labeling
chemical_list: D007166:Immunosuppressive Agents; D007555:Isoxazoles; D003561:Cytarabine; D000077339:Leflunomide